Antiangiogenic agents targeting different angiogenic pathways have opposite effects on tumor hypoxia in R-18 human melanoma xenografts

BACKGROUND: Studies comparing the effect of antiangiogenic agents targeting different angiogenic pathways are sparse. The purpose of this study was to compare the effect of properdistatin and sunitinib treatment in a preclinical model of malignant melanoma. Properdistatin is a small peptide derived...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaustad, Jon-Vidar, Simonsen, Trude G., Andersen, Lise Mari K., Rofstad, Einar K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469039/
https://www.ncbi.nlm.nih.gov/pubmed/28606060
http://dx.doi.org/10.1186/s12885-017-3404-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469039/
https://www.ncbi.nlm.nih.gov/pubmed/28606060
http://dx.doi.org/10.1186/s12885-017-3404-4

Ejemplares similares